glutamate in the patients relative to controls. Furthermore, reduced GABA and elevated glutamate in STG should be related to severity of auditory hallucinations in these patients. Methods: The current study tested 23 schizophrenia patients (18 hallucinating and 5 non-hallucinating) and 53 healthy controls. The sample included both female and male participants above the age of 18. All patients were on medication, and they were tested at different times relative to the treatment onset. Magnetic resonance spectroscopy (MRS) was used to acquire data from voxels in the right and left superior temporal gyrus (Heschl's gyri) with a 3T GE 750 Discovery MR scanner. PRESS and MEGA-PRESS sequences were applied to measure glutamate and GABA, respectively. Voxel tissue water was used as reference for glutamate and GABA. Scores on the Positive and Negative Syndrome Scale (PANSS) were also collected, and used to differentiate hallucinating from non-hallucinating patients. Results: Separate 2(Group) x 2(Hemisphere) ANOVAs were estimated for GABA and glutamate. No main or interaction effects came out significant for GABA (All F(1,73)<2.7, p>0.1, η2<0.03). The analysis for glutamate resulted in a main effect of Hemisphere (F(1,74)=24, p<0.001, η2=0.25) in which the right STG showed overall higher concentrations than the left STG. In addition, an interaction effect between Group and Hemisphere was found (F(1,74)=5.22, p=0.03, η2=0.07). Bonferroni Post-hoc analysis showed significantly elevated glutamate levels in patients relative to controls in the right STG only (p=0.005). Furthermore, a multiple regression analysis was estimated between severity of hallucinations (PANSS P3 item) at the time of testing, and GABA and glutamate values in left and right STG. Although the overall model fit was non-significant, an approximate significant correlation was found between hallucination severity and left STG glutamate levels (β=0.36, t=2.1, SE=0.17, p=0.05). Discussion: The present study found higher glutamate levels in schizophrenia patients relative to healthy controls in the right STG. In spite of no overall differences in glutamate in the left STG, as initially hypothesized, glutamate levels in this region was found to predict severity of auditory hallucinations. One could speculate that the additional neuronal activity associated with auditory hallucinations elevate glutamate to 'normal levels' corresponding to that of healthy controls. The increased glutamate levels in the right STG seems (linearly) unrelated to auditory hallucinations and future analysis should test whether other symptoms are related to this finding. Overall, the study found only limited support for the GABA-glutamate hypothesis; In spite of increased glutamate in one of the regions, GABA was not found to be reduced in patients and was unrelated to auditory hallucinations. 
F185. BRAIN STRUCTURAL PATTERNS DIFFERENTIATE EARLY-AND LATE-ONSET CANNABIS USE IN PSYCHOTIC PATIENTS

Ludwig Maximilian University
Background: Cannabis use is considered to be one of the most important environmental risk factors for developing psychosis. Previous research indicates that consumption which is initiated during adolescence is associated with a higher risk of adverse effects. It has been proposed that in this period cannabis use may be more harmful due to the disruptive impact on the endocannabinoid system which is critically involved in brain development. Multiple studies indicate structural brain alterations in patients with schizophrenia as well as in cannabis users. However, the effect of cannabis use on brain development in patients with psychosis is currently only poorly understood. Thus, in the current analysis we employed a multivariate approach to investigate the hypothesis that early cannabis use might be associated with marked alterations in brain structure that are distinct from alterations in late-users. Methods: n=39 patients with recent onset psychosis (ROP) and cannabis abuse of the PRONIA sample took part in a structural MRI (sMRI) scan and were clinically assessed with respect to their cannabis use characteristics and psychotic symptoms using the positive and negative symptoms scale (PANSS). Patients were grouped into early-users (n=21, onset before age of 18) and late-users (n=18, onset after age of 18). Multivariate pattern classification was performed on the basis of sMRI data to differentiate early-and late-users. Results: Early-and late-users did not differ with respect to age, gender or amount of current cannabis use. Early-users showed significantly higher PANSS scores compared to late-users (p < 0.05). Structural MRI allowed the differentiation between early-and late-users with 72 % (81 % of the early-users, 61 % of the late-users). Discussion: The current results indicate a distinction between psychotic patients with cannabis abuse who started to consume before the age of 18 and those who did later in life. The groups could be distinguished by means both of their clinical data, i.e., more severe psychotic symptoms in the early-users, and of their neuroanatomical data. These findings are in line with former literature, indicating that cannabis use during the period of adolescence is associated with persistent and more severe negative outcomes than use which is initiated in the adulthood. However, due to the relatively low sample size, these results serve only as preliminary results and need further investigation. Background: Diffusion tensor imaging (DTI) studies have shown white-matter (WM) abnormalities in most corpus callosum segments in first-episode psychosis (FEP) patients. However, the tapetum, one of its sub-segments, is not fully studied until now. This study focuses on tapetum and its relationship with psychotic disorders using DTI with symptom severities and duration of untreated psychosis (DUP). Methods: Ninety-five FEP patients and thirty healthy controls (HCs) were enrolled. Tapetum, region of interest was extracted using 3D slicer and tract-based spatial statistics (TBSS) were used for DTI analysis. All patients were assessed DUP and clinical symptoms by Scale for the Assessment of Positive Symptoms (SAPS), Scale for the Assessment of Negative Symptoms (SANS) at baseline. Results: TBSS revealed that fractional anisotropy (FA) values of tapetum in FEP is significantly decreased compared to HCs (p<0.01, . Exploratory correlational analysis revealed significant negative correlations between FA values of left tapetum and baseline SAPS total scores (r =-0.278, p<0.05), bizarre behavior subscale scores (r =-0.310, p<0.01), positive formal thought disorder subscale scores (r =-0.348, p<0.01), inappropriate affect subscale scores (r =-0.315, p<0.01) and SANS avolitionapathy subscale scores (r =-0.257, p<0.05). Also FA values of left tapetum was negatively correlated with DUP (r =-0.426, p<0.00). Discussion: FEP patients show a significant reduction in WM integrity of left tapetum, also show correlation with clinical symptoms and DUP. These results suggested that left tapetum may play a role in symptom severities and prognosis in FEP. 
F186. TAPETUM ABNORMALITIES IN FIRST-EPISODE PSYCHOSIS AND RELATIONSHIP TO SYMPTOM SEVERITY AND DURATION OF UNTREATED PSYCHOSIS
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